Invesco Pharmaceuticals E... (PJP)
NYSEArca: PJP
· Echtzeitkurs · USD
126.15
+0.79 (0.63%)
Zum Schluss: Aug 17, 2026, 3:59 PM
Invesco Pharmaceuticals ETF (PJP) Stock Price, Analysis & Data
0.63% (1D)
| Geld | n/a |
| Marktkapitalisierung | n/a |
| Umsatz (TTM) | n/a |
| Nettogewinn (TTM) | n/a |
| Beta | n/a |
| EPS (ttm) | n/a |
| KGV (TTM) | 23.15 |
| Forward-KGV | n/a |
| KBV (TTM) | 1.30 |
| KUV (TTM) | n/a |
| Earnings Date | n/a |
| Brief | n/a |
| Volumen | 6,735 |
| Ø Vol. (20D) | 33,401 |
| Eröffnung | 125.19 |
| Vortagesschluss | 125.36 |
| Tagesspanne | 125.38 - 126.53 |
| 52-Wk Range | 89.63 - 126.53 |
| Analyst | n/a |
| Kursziel | n/a |
| Dividenden | n/a |
| Ex-Dividenden-Datum | n/a |
Über PJP
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of common stocks of 30 U.S. pharmaceutical companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified....
Vollständiges UnternehmensprofilFinanzielle Entwicklung
Im Jahr undefined betrug der Umsatz von Invesco Pharmaceuticals ETF n/a, ein Anstieg von undefined% im Vergleich zum Vorjahr (n/a). Der Gewinn lag bei n/a, ein Anstieg von undefined %.
FinanzberichteSeite 1 von 2
